News | November 25, 2021
ADB approves US $ 1.5 bn for Covid-19 vaccines in India
The loan will fund at least 667 million Covid-19 vaccine doses for an estimated 317 million people
The loan will fund at least 667 million Covid-19 vaccine doses for an estimated 317 million people
.jpg)
Molbio Diagnostics has been the pioneer in providing access to molecular testing through its Truenat Real Time PCR platform. Sriram Natarajan, Director & CEO, of the company shares his experiences on the journey so far in an interview with Thomas C Thottathil
The nutraceutical sector is on the cusp of exponential growth and Covid-19 has accelerated the pace of its applications. Dr R.B Smarta, CMD, Interlink, shares his perspective on the growth opportunities and challenges for the sector
If approved or authorized, Paxlovid would be the first oral antiviral of its kind, to combat SARS-CoV-2
The aim is to support Pharmacovigilance programme across the countries in the region
The octocopter has successfully delivered 50 vials of Covid-19 vaccines along with syringes in a special container from Chandapura PHC to Haragadde PHC
The rise in cases amongst the young is a cause for concern. A few specialists gave us a perspective on the issue
Covaxin is the only Covid-19 vaccine to have demonstrated efficacy data from phase III clinical trials against the Delta variant at 65.2%
Thermo Fisher Scientific expands diagnostics portfolio to support full qPCR assay development and testing workflow
In the overall study population through Day 28, no deaths were reported in patients who received Paxlovid as compared to 10 deaths in patients who received placebo
Subscribe To Our Newsletter & Stay Updated
